戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 arrhythmogenic remodeling from ARVC and post-inflammatory cardiomyopathy.
2              Myocarditis has also been named inflammatory cardiomyopathy.
3  the treatment of autoimmune myocarditis and inflammatory cardiomyopathy.
4 eposition of collagen fibers, all leading to inflammatory cardiomyopathy.
5 diated autoimmune myocarditis and subsequent inflammatory cardiomyopathy.
6 py are effective for chronic, virus-negative inflammatory cardiomyopathy.
7 or the development of myocardial fibrosis in inflammatory cardiomyopathy.
8 is and might serve as therapeutic targets in inflammatory cardiomyopathies.
9 arrhythmogenic remodeling from ARVC and post-inflammatory cardiomyopathies.
10 in the pathogenesis of diabetic, genetic and inflammatory cardiomyopathies.
11 ation and in the myocardium of patients with inflammatory cardiomyopathies.
12  endomyocardial biopsy for the management of inflammatory cardiomyopathies.
13 s, 6392 [5710-6836] AU; adult myocarditis or inflammatory cardiomyopathy, 5688 [5277-5990] AU; health
14 treatment recommendations for AM and chronic inflammatory cardiomyopathy are mainly based on expert o
15        Cardiac sarcoidosis (CS) is a form of inflammatory cardiomyopathy associated with significant
16 elop chronic Chagas cardiomyopathy (CCC), an inflammatory cardiomyopathy characterized by hypertrophy
17                                              Inflammatory cardiomyopathy, characterized by inflammato
18                  Despite extensive research, inflammatory cardiomyopathy complicated by left ventricu
19 ials suggest that some patients with chronic inflammatory cardiomyopathy have a progressive clinical
20 cine myocarditis, adults with myocarditis or inflammatory cardiomyopathy, healthy children prior to t
21  battle against invading pathogens, limiting inflammatory cardiomyopathy, heart failure, and death.
22 tients with dilated cardiomyopathy (DCM) and inflammatory cardiomyopathy (ICM).
23  with nonischemic dilated cardiomyopathy and inflammatory cardiomyopathy (iCMP).
24 etter understand the pathogenesis of complex inflammatory cardiomyopathy, if conducted on a larger sc
25                     The most common cause of inflammatory cardiomyopathies in developed countries is
26             We recently described a model of inflammatory cardiomyopathy in interferon (IFN)-gamma ov
27 ects, and the evidence base for treatment of inflammatory cardiomyopathy in patients with rheumatic I
28 ommon causative agents in the development of inflammatory cardiomyopathy include cardiotropic viruses
29                                              Inflammatory cardiomyopathies including myocarditis and
30                         In contrast, chronic inflammatory cardiomyopathy indicates myocardial inflamm
31 itochondrial involvement in the pathology of inflammatory cardiomyopathy is multifaceted and complex.
32                         We hypothesized that inflammatory cardiomyopathy is potentially related to mi
33                                              Inflammatory cardiomyopathy is predominantly mediated by
34 lthough the clinical course of acute, severe inflammatory cardiomyopathy is well described, the effec
35 f the HMGB1-RAGE axis in the pathogenesis of inflammatory cardiomyopathy is yet not fully understood.
36 trophic cardiomyopathy, cardio-oncology, and inflammatory cardiomyopathies like myocarditis and sarco
37 ears; 10 male), 8 adults with myocarditis or inflammatory cardiomyopathy (median age, 55 [46-63] year
38 onic Chagas disease cardiomyopathy (CCC), an inflammatory cardiomyopathy presenting with heart failur
39                                 In contrast, inflammatory cardiomyopathies refer to a diverse group o
40                   Chagas heart disease is an inflammatory cardiomyopathy that develops in approximate
41  For most BTR subjects presenting with acute inflammatory cardiomyopathy, ventricular recovery was ma
42                        Definite ARVC or post-inflammatory cardiomyopathy was diagnosed in 40 (87%) of
43 osclerotic cardiovascular disease (ASCVD) to inflammatory cardiomyopathy, which comprises myocardial
44 , diagnosis and treatment of myocarditis and inflammatory cardiomyopathy, with a special focus on vir
45 1 in mouse cardiomyocytes creates a model of inflammatory cardiomyopathy, with death from heart failu